Dr Reddy’s Laboratories has moved higher by 2% at Rs 1,760 after the company said it has launched Metoprolol Succinate tablets used for treating high blood pressure in the American market.
“The company has launched Metoprolol Succinate extended- release tablets in the strengths of 25 mg, 50 mg, 100 mg and 200 mg in the US market,” Dr Reddy's Laboratories said in a statement.
Toprol-XL and its generics had sales of nearly $1.13 billion in the US for the 12- month period ending June, 2012, according to IMS Health data, the pharma company said.
The stock opened at Rs 1,735 and touched high of Rs 1,762 on the NSE. A total 247,807 shares have changed hands on the counter so far on the NSE and BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app